pneumococc
infect
lead
caus
communityacquir
pneumonia
although
type
wellknown
antivir
cytokin
role
antipneumococc
host
defens
therapeut
potenti
remain
poorli
understood
investig
issu
use
murin
transgen
express
model
found
control
anim
streptococcu
pneumonia
infect
caus
sever
weight
loss
excess
lung
inflamm
associ
rapid
bacteri
outgrowth
contrast
anim
receiv
singl
dose
adenovir
vector
express
prior
pneumococc
infect
demonstr
rapid
effect
control
bacteri
replic
lung
inflamm
improv
clinic
outcom
enhanc
protect
due
increas
activ
neutrophil
macrophag
increas
releas
reactiv
oxygen
nitrogen
speci
bacteri
kill
furthermor
found
rais
level
lung
remain
immun
protect
even
gene
transfer
vector
given
time
postpneumococc
infect
studi
thu
show
classic
antivir
type
ifn
exploit
enhanc
immun
pneumococc
infect
via
activ
effect
innat
immun
cell
find
hold
implic
therapeut
use
gene
transfer
strategi
combat
pneumococc
infect
control
pneumococc
infect
damjanov
et
al
streptococcu
pneumonia
remain
major
human
pathogen
worldwid
pneumococc
infect
lead
caus
communityacquir
pneumonia
lead
invas
pneumococc
diseas
includ
bacteremia
septicemia
pneumonia
mening
estim
communityacquir
pneumonia
alon
account
million
physician
visit
hospit
annual
canada
cost
million
incid
invas
pneumococc
diseas
adult
remain
high
wherea
highest
incid
elderli
children
less
year
age
particularli
aborigin
children
live
northern
canada
worldwid
pneumonia
continu
signific
bacteri
pathogen
children
caus
prevent
death
children
less
year
age
million
infant
death
per
year
develop
countri
addit
pneumonia
superinfect
common
complic
influenza
togeth
form
lead
caus
death
infecti
diseas
canada
alarmingli
pneumonia
outbreak
occur
across
canada
elsewher
north
america
last
year
treatment
complic
continu
emerg
antibioticresist
pneumonia
serotyp
narrow
serotypespecif
protect
provid
conjug
polysaccharid
vaccin
evershift
bacteri
serotyp
away
serotyp
cover
vaccin
invas
infect
vaccin
children
thu
press
need
enhanc
understand
host
defens
mechan
develop
novel
therapeut
agent
pneumococc
diseas
particularli
caus
antibiot
resist
strain
type
interferon
ifn
mainli
produc
viral
intracellular
bacteri
infect
research
focus
classic
antivir
role
type
ifn
regard
replicationdefici
human
type
adenoviru
vector
express
human
consensu
gene
known
develop
antivir
drug
test
prophylact
therapeut
experiment
model
demonstr
protect
efficaci
ebola
viru
yellow
fever
viru
arenaviru
phleboviru
infect
singl
dose
likewis
vector
express
mous
shown
protect
lethal
sever
acut
respiratori
syndrom
sar
viru
western
equin
enceph
viru
venezuelan
equin
enceph
viru
pox
vaccinia
viru
infect
spite
much
establish
knowledg
role
type
ifn
therapeut
effect
viral
infect
still
remain
poorli
understood
role
therapeut
potenti
articl
extracellular
bacteri
infect
past
recent
evid
hint
benefici
role
type
ifn
pneumonia
infect
current
studi
investig
role
host
defens
therapeut
potenti
pneumonia
infect
use
murin
model
acut
pneumococc
infect
gene
transfer
vector
express
provid
novel
evid
transgen
rais
level
lung
provid
enhanc
immun
protect
acut
pneumonia
infect
via
activ
effect
neutrophil
macrophag
find
hold
implic
use
type
ifn
transgen
approach
immunotherapi
pneumococc
pneumonia
rapid
pneumonia
replic
pronounc
immunopatholog
deleteri
clinic
outcom
control
anim
hour
upon
pulmonari
pneumonia
infect
control
mice
receiv
empti
control
ad
vector
infect
addl
group
figur
found
minim
detect
level
type
lung
figur
mice
suffer
progress
deterior
bodi
weight
loss
figur
associ
heighten
immunopatholog
includ
intrabronchi
hemorrhag
lung
figur
death
day
postinfect
figur
examin
bacteri
burden
high
level
pneumonia
count
found
hour
lung
spleen
figur
black
bar
data
suggest
control
anim
difficulti
effect
control
pneumonia
infect
system
dissemin
associ
tissu
inflamm
lung
gene
transfer
control
pneumonia
replic
immunopatholog
improv
clinic
outcom
given
minim
level
detect
lung
pneumonia
infect
control
addl
mice
figur
set
determin
role
rais
lung
level
host
defens
pneumonia
infect
end
use
transient
transgen
approach
express
lung
deliv
recombin
replicationdefect
gene
transfer
vector
encod
pneumonia
infect
thu
contrast
minim
level
lung
mice
receiv
empti
vector
addl
pneumonia
infect
figur
mice
receiv
significantli
rais
level
lung
pneumonia
infect
hour
figur
also
elev
circul
level
mice
supplementari
figur
compar
addl
control
level
remain
rais
lung
hour
pneumonia
infect
figur
found
elev
level
significantli
reduc
bodi
weight
loss
mice
monitor
measur
overal
ill
figur
thu
small
transient
bodi
weight
loss
hour
poststrep
infect
mice
sharp
contrast
bodi
weight
loss
hour
respect
control
mice
figur
addit
although
control
mice
reach
end
point
day
postinfect
death
observ
group
figur
consist
improv
surviv
immunopatholog
tissu
injuri
much
reduc
lung
mice
figur
furthermor
bacteri
load
lung
spleen
mice
dramat
multipl
log
lower
compar
control
counterpart
figur
find
suggest
transgen
rais
level
immun
protect
acut
pneumococc
pneumonia
capabl
effect
control
pneumonia
replic
improv
lung
immunopatholog
clinic
outcom
gene
transfer
lead
rapid
induct
innat
immun
cellular
infiltr
cytokin
respons
lung
upon
pneumonia
infect
begin
investig
mechan
improv
bacteri
control
clinic
outcom
mediat
gene
transfer
lung
first
analyz
innat
cellular
respons
lung
hour
poststrep
use
flow
cytometri
total
inflammatori
infiltr
number
almost
threefold
higher
respiratori
tract
bronchoalveolar
lavag
bal
mice
compar
control
tabl
account
primarili
markedli
increas
neutrophil
influx
bal
figur
b
higher
cell
number
neutrophil
influx
also
observ
hour
mice
tabl
data
shown
comparison
neutrophil
number
lung
parenchyma
similar
two
group
macrophag
bal
lung
parenchyma
figur
addit
neutrophil
appear
moder
increas
natur
killer
nk
cell
cell
lung
parenchyma
mice
supplementari
figur
data
suggest
alter
innat
immun
cellular
respons
might
involv
enhanc
immun
protect
gene
transfer
given
increas
neutrophil
respons
bal
gene
transfer
next
assess
cytokin
chemokin
level
bal
hour
follow
pneumonia
infect
inde
compar
control
anim
level
proinflammatori
cytokin
tumor
necrosi
increas
mice
figur
associ
increas
proinflammatori
cytokin
higher
level
chemokin
includ
neutrophil
chemoattract
macrophag
inflammatori
protein
keratinocytederiv
chemokin
kc
figur
result
togeth
show
rais
level
enhanc
host
defens
pneumonia
infect
via
rapid
induct
cytokin
respons
innat
cellular
respons
lung
earli
time
point
postinfect
thu
lead
better
control
bacteri
replic
immunopatholog
rapidli
diminish
tissu
inflammatori
respons
induc
gene
transfer
latter
stage
pneumonia
infect
investig
potenti
mechan
improv
clinic
outcom
gene
transfer
examin
innat
cellular
cytokin
respons
later
time
point
hour
pneumonia
infect
control
mice
approach
end
point
figur
uncontrol
lung
inflamm
figur
bacteri
outgrowth
figur
time
mice
remark
diminish
number
neutrophil
bal
lung
parenchyma
compar
control
mice
figur
number
macrophag
also
markedli
decreas
bal
mice
figur
rapid
clearanc
cellular
infiltr
lung
mice
associ
sharp
declin
proinflammatori
cytokin
chemokin
figur
contrari
higher
level
cytokin
hour
poststrep
infect
figur
hand
hour
control
mice
excess
influx
neutrophil
macrophag
bal
lung
figur
correspond
total
inflammatori
cell
airway
tabl
heighten
inflammatori
cellular
respons
control
anim
associ
sustain
proinflammatori
cytokin
tumor
necrosi
remark
increas
level
pgml
chemokin
figur
data
suggest
earlier
increas
innat
immun
respons
induc
gene
transfer
lead
rapid
control
bacteri
infect
help
lung
return
homeostasi
hand
control
anim
markedli
heighten
inflammatori
respons
due
uncontrol
bacteri
infect
enhanc
neutrophil
respons
contribut
improv
bacteri
clearanc
gene
transfer
assess
mechan
increas
bacteri
control
rais
level
measur
reactiv
oxygen
speci
ro
reactiv
nitrogen
speci
rn
hydrogen
peroxid
peroxyl
radic
nitric
oxid
peroxynitrit
anion
lung
homogen
collect
variou
time
point
poststrep
infect
given
critic
antibacteri
activ
associ
activ
neutrophil
macrophag
significantli
increas
level
rosrn
induc
hour
equal
level
control
mice
postinfect
figur
largest
differ
rosrn
two
group
seen
postinfect
figur
correspond
high
neutrophil
influx
lung
mice
rais
level
time
point
figur
base
rosrn
data
investig
role
increas
neutrophil
improv
bacteri
control
end
undertook
strategi
allow
partial
neutrophil
deplet
lung
mice
prior
pneumonia
infect
thu
mice
receiv
gene
transfer
vector
depict
figur
treat
neutrophildeplet
antibodi
hour
pneumonia
infect
control
mice
receiv
control
immunoglobulin
g
flow
cytometri
protocol
found
render
reduct
neutrophil
pneumoniaeinfect
mice
postinfect
reduct
hour
neutrophil
influx
continu
lung
supplementari
figur
found
partial
neutrophil
deplet
led
significantli
greater
weight
loss
figur
worsen
bacteri
control
lung
spleen
figur
markedli
reduc
measur
rosrn
lung
figur
nevertheless
notabl
extent
bodi
weight
loss
increas
bacteri
load
partial
neutrophildeplet
anim
reach
previous
seen
addl
control
group
figur
e
data
togeth
suggest
enhanc
neutrophil
respons
induc
gene
transfer
contribut
improv
bacteri
clearanc
clinic
outcom
improv
macrophag
phagocyt
kill
pneumonia
transgen
express
observ
neutrophil
deplet
mice
result
significantli
reduc
complet
elimin
enhanc
protect
figur
suggest
addit
mechan
play
although
express
increas
number
macrophag
lung
figur
possibl
antibacteri
properti
innat
immun
cell
alter
examin
possibl
freshli
isol
naiv
alveolar
macrophag
am
purifi
lung
macrophag
mo
transduc
vitro
express
treat
control
vector
addl
viabl
streptococci
ad
macrophag
control
am
lung
mo
produc
signific
level
measur
cultur
media
supplementari
figur
am
lung
mo
also
produc
much
higher
level
antibacteri
rosrn
upon
bacteri
phagocytosi
control
counterpart
figur
importantli
am
three
time
effect
bacteri
kill
produc
figur
comparison
although
kill
effici
similar
hour
lung
mo
significantli
effect
bacteri
kill
hour
compar
produc
ceas
kill
streptococci
time
figur
data
indic
besid
neutrophil
activ
alveolar
lung
macrophag
express
repres
addit
mechan
enhanc
immun
protect
improv
bacteri
control
therapeut
gene
transfer
render
pneumonia
infect
control
bacteri
replic
improv
clinic
outcom
determin
therapeut
potenti
pneumococc
infect
mice
infect
pneumonia
hour
later
inocul
addl
control
vector
figur
bodi
weight
loss
similar
two
group
initi
cours
infect
mice
experienc
stall
bodi
weight
loss
hour
began
recov
hour
lead
death
group
day
postinfect
figur
sharp
contrast
control
mice
exhibit
progress
deterior
clinic
condit
approach
end
point
soon
hour
death
group
day
postinfect
figur
consist
improv
clinic
outcom
induc
lung
mice
markedli
reduc
immunopatholog
inflamm
primarili
limit
peribronchi
perivascular
region
figur
contrast
control
lung
sever
diffus
tissu
immunopatholog
inflamm
figur
also
consist
improv
clinic
outcom
immunopatholog
induc
therapeut
gene
transfer
mice
significantli
lower
bacteri
load
lung
spleen
compar
control
mice
figur
almost
onelog
differ
colonyform
unit
cfu
lung
figur
correl
signific
improv
lung
patholog
figur
weight
loss
surviv
figur
find
togeth
support
therapeut
potenti
rais
lung
use
gene
transfer
strategi
effect
control
pneumonia
infect
associ
detriment
clinic
outcom
infect
pneumonia
continu
signific
clinic
social
econom
impact
canada
worldwid
lead
caus
communityacquir
pneumonia
invas
pneumococc
diseas
signific
bacteri
pathogen
children
common
complic
influenza
pneumonia
contribut
signific
morbid
mortal
worldwid
treatment
complic
continu
emerg
antibioticresist
strain
suboptim
vaccin
make
threat
pneumonia
outbreak
realiti
role
therapeut
potenti
type
ifn
host
defens
extracellular
intriguingli
recent
demonstr
pneumonia
activ
type
ifn
signal
emerg
evid
suggest
benefici
role
type
ifn
pneumonia
infect
howev
protect
effect
fulli
establish
mechan
protect
entir
unknown
use
mous
model
acut
respiratori
pneumonia
infect
gene
transfer
approach
investig
outstand
issu
show
pneumonia
infect
lead
rapid
uncontrol
pneumonia
replic
pronounc
immunopatholog
deleteri
clinic
outcom
control
anim
amelior
transgen
express
lung
enhanc
immun
protect
acut
pneumonia
infect
induc
via
rapid
induct
innat
immun
cellular
infiltr
cytokin
respons
lung
activ
effect
neutrophil
macrophag
first
time
also
provid
novel
therapeut
strategi
singl
dose
administ
ongo
pneumonia
infect
control
bacteri
replic
improv
clinic
outcom
model
pulmonari
pneumococc
infect
mice
infect
pneumonia
hour
receiv
one
dose
addl
control
control
mice
bare
detect
level
lung
consequ
mice
suffer
rapid
bodi
weight
loss
process
reach
end
point
postinfect
poor
clinic
outcom
associ
heighten
immunopatholog
lung
high
level
bacteri
burden
local
lung
system
spleen
thu
control
anim
major
difficulti
effect
control
pneumonia
infect
model
hand
mice
markedli
rais
level
lung
serum
time
infect
measur
variou
time
point
pneumonia
infect
bal
express
induc
mice
thu
adenoviru
vector
provid
sustain
induc
express
found
rais
level
significantli
c
averag
percent
bodi
weight
chang
surviv
monitor
end
point
consid
bodi
weight
loss
logrank
test
p
lung
spleen
bacteri
load
measur
use
cfu
assay
last
time
point
result
two
independ
experi
n
data
express
mean
sem
p
p
ifn
interferon
reduc
bodi
weight
loss
mice
small
transient
bodi
weight
loss
postinfect
markedli
improv
surviv
rate
consist
improv
clinic
outcom
immunopatholog
tissu
injuri
dramat
reduc
lung
mice
compar
control
anim
bacteri
load
lung
spleen
find
show
rais
level
immun
protect
acut
pneumococc
pneumonia
control
pneumonia
replic
immunopatholog
improv
clinic
outcom
studi
next
investig
unknown
mechan
improv
bacteri
control
clinic
outcom
mediat
gene
transfer
observ
cytokin
chemokin
level
airway
mice
earli
pneumonia
infect
hour
markedli
higher
compar
control
mice
like
cellular
sourc
heighten
chemokin
includ
airway
epitheli
cell
neutrophil
macrophag
increas
cytokin
chemokin
correl
rapid
infiltr
immun
cell
airway
lung
parenchyma
includ
neutrophil
nk
cell
cell
recent
nk
cell
cell
shown
import
role
earli
host
defens
extracellular
bacteria
importantli
higher
neutrophil
number
airway
indic
improv
bacteri
control
neutrophil
known
key
phagocyt
involv
pneumonia
clearanc
level
ro
rn
also
significantli
higher
lung
mice
throughout
infect
correl
improv
bacteri
clearanc
partial
deplet
neutrophil
infect
show
neutrophil
number
activ
lung
express
mice
contribut
observ
improv
bacteri
clearanc
clinic
outcom
furthermor
macrophag
also
known
major
cell
involv
first
line
defens
site
infect
found
increas
number
mice
investig
function
potenti
mechan
improv
bacteri
control
am
purifi
lung
macrophag
display
effici
pneumonia
kill
increas
releas
rosrn
effect
control
bacteri
outgrowth
previous
infect
oppos
addl
thu
heighten
macrophag
neutrophil
activ
earlier
time
point
anim
like
led
much
increas
amount
rosrn
lung
contribut
sustain
level
rosrn
later
time
bacteria
larg
clear
lung
anim
similar
amount
rosrn
two
group
later
time
point
hour
like
result
sustain
ro
rn
product
group
due
last
macrophag
activ
rel
markedli
increas
rosrn
product
control
group
time
point
due
persist
high
bacteri
burden
increas
rosrn
product
lung
may
repres
one
key
mechan
enhanc
antipneumococc
host
defens
oxygen
nitrogen
speci
known
critic
neutrophil
macrophag
antibacteri
activ
studi
therefor
reveal
mechan
mediat
provid
improv
bacteri
control
clinic
outcom
pneumonia
infect
importantli
latter
stage
pneumonia
infect
hour
mice
exhibit
larg
diminish
tissu
inflammatori
respons
thu
express
led
rapid
control
bacteri
infect
allow
lung
return
homeostasi
deleteri
effect
lung
inflamm
could
caus
irrepar
damag
hand
control
mice
display
strikingli
heighten
ongo
inflammatori
respons
due
uncontrol
bacteri
infect
adenoviru
use
studi
propos
novel
broadspectrum
drug
proven
success
provid
protect
larg
varieti
virus
report
im
inject
rapidli
lead
high
level
serum
within
hour
infect
undetect
day
howev
protect
effect
ifn
sustain
anim
challeng
western
equin
enceph
viru
day
administr
protect
addit
deliveri
observ
protect
given
day
infect
sar
vaccinia
viru
respect
also
previous
shown
gene
transfer
vector
deliveri
lead
sustain
transgen
express
within
airway
epithelium
macrophag
period
day
thu
singl
dose
abl
induc
longlast
antivir
state
activ
protect
immun
mechan
accordingli
next
investig
therapeut
potenti
vector
pneumococc
infect
mice
infect
pneumonia
hour
later
inocul
addl
control
vector
therapeut
express
led
significantli
lower
bacteri
replic
improv
lung
immunopatholog
clinic
outcom
surviv
significantli
improv
mice
aliv
day
postinfect
control
anim
surviv
note
therapeut
applic
result
moder
reduc
bacteri
burden
lung
yet
markedli
reduc
lung
immunopatholog
clinic
outcom
suggest
moder
improv
infect
control
part
mechan
improv
histopatholog
recent
mount
evid
indic
lung
immunopatholog
alway
correl
level
microbi
burden
immun
regulatori
mechan
directli
involv
host
defens
also
play
import
role
regul
tissu
inflamm
suggest
addit
regulatori
function
possess
model
protect
effect
transgen
express
agreement
two
previou
studi
approach
question
murin
studi
weigent
et
al
show
either
recombin
markedli
improv
surviv
streptococc
infect
administ
ip
hour
infect
surviv
compar
surviv
control
studi
serum
significantli
increas
mortal
surviv
compar
surviv
control
similarli
colon
model
studi
parker
et
al
receptor
null
mice
significantli
increas
nasal
colon
pneumonia
compar
wildtyp
mice
therefor
find
support
therapeut
potenti
transgen
express
lung
effect
control
pneumonia
infect
associ
detriment
clinic
outcom
conclus
result
indic
classic
antivir
cytokin
also
protect
extracellular
bacteri
infect
pneumonia
furthermor
identifi
first
time
singl
dose
lead
rapid
effect
control
bacteri
replic
lung
inflamm
consequ
improv
clinic
outcom
find
hold
import
implic
transgen
express
futur
clinic
practic
particular
outbreak
rapid
therapi
site
infect
would
invalu
pneumococc
infect
pneumonia
serotyp
atcc
prepar
previous
describ
plate
frozen
stock
bloodagar
plate
incub
overnight
cultur
result
coloni
hour
co
todd
hewitt
broth
bd
bioscienc
san
jose
ca
midlogarithm
phase
bacteria
harvest
resuspend
phosphatebuff
salin
pb
anesthet
mice
infect
cfu
pneumonia
volum
prophylact
therapeut
gene
deliveri
lung
replicationdefici
adenovir
gene
transfer
vector
express
murin
obtain
defyru
toronto
ontario
canada
construct
prepar
robert
fitzhenri
vector
laboratori
mcmaster
univers
empti
adenovir
vector
addl
use
control
mice
anesthet
inhal
isofluran
infect
plaqueform
unit
volum
hour
prophylact
hour
therapeut
pneumonia
infect
previous
well
document
gene
transfer
vector
deliveri
lead
transgen
express
within
airway
epithelium
macrophag
rais
transgen
protein
level
period
day
determin
streptococcu
burden
local
system
tissu
level
streptococcu
lung
spleen
determin
homogen
tissu
pb
plate
serial
dilut
bloodagar
plate
incub
overnight
co
coloni
count
calcul
cfu
per
whole
organ
airway
lumin
cell
collect
bal
lung
mononuclear
cell
isol
lung
tissu
use
standard
procedur
previous
describ
briefli
lung
cut
small
piec
incub
ml
uml
collagenas
type
sigmaaldrich
st
loui
mo
hour
lung
piec
crush
basket
filter
red
blood
cell
lyse
ammoniumchloridepotassium
ack
lysi
buffer
cell
pellet
resuspend
complet
rpmi
medium
rpmi
supplement
fetal
bovin
serum
penicillinstreptomycin
lglutamin
flow
cytometri
perform
bal
lung
cell
cell
incub
minut
fc
block
antibodi
stain
extracellular
antibodi
bd
bioscienc
unless
otherwis
state
antigenpres
cell
alexa
fluor
ebiosci
san
diego
ca
pacif
life
technolog
burlington
ontario
nk
cell
cell
stain
cell
analyz
lsrii
flow
cytomet
bd
bioscienc
analyz
use
flowjo
softwar
tree
star
ashland
neutrophil
macrophag
nk
cell
cell
assess
total
number
cell
per
tissu
compart
multipli
frequenc
total
popul
total
cell
number
tissu
